<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37586763</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2053-8790</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Lupus science &amp; medicine</Title><ISOAbbreviation>Lupus Sci Med</ISOAbbreviation></Journal><ArticleTitle>Abnormally high expression of D1-like dopamine receptors on lupus CD4<sup>+</sup> T cells promotes Tfh cell differentiation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e000943</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/lupus-2023-000943</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">SLE is a chronic autoimmune disease that places a great burden on human society. T follicular helper (Tfh) cells play a critical role in the pathological process of SLE. Therefore, elucidating the mechanism of Tfh cell differentiation will contribute to SLE treatment. Dopamine receptors (DRDs) are members of the family of G protein-coupled receptors and are primarily divided into D1-like and D2-like receptors. Previous studies have found that DRDs can regulate differentiation of immune cells. However, there is currently a lack of research on DRDs and Tfh cells. We here explore the relationship between DRDs and Tfh cells, and analyse the relationship between DRD expression on Tfh cells and the course of SLE.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We first detected plasma catecholamine concentrations in patients with SLE and healthy controls by mass spectrometry, followed by reverse transcription-quantitative PCR (RT-qPCR) to detect DRD messenger RNA (mRNA) expression in peripheral blood mononuclear cells (PBMCs) and CD4<sup>+</sup> T cells, and flow cytometry to detect DRD expression in Tfh cells. Finally, in vitro experiments and RNA sequencing (RNA-seq) were used to explore the possible pathway by which DRDs regulate Tfh cell differentiation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The plasma dopamine concentration in patients with SLE was significantly increased, and abnormal mRNA expression of DRDs was observed in both PBMCs and CD4<sup>+</sup> T cells. The results of flow cytometry showed that D1-like receptors were highly expressed in Tfh cells of patients with SLE and associated with disease activity. In vitro induction experiments showed that differentiation of na&#xef;ve T cells into Tfh cells was accompanied by an increase in D1-like receptor expression. RNA-seq and RT-qPCR results indicate that D1-like receptors might promote Tfh cell differentiation through the Phosphatidylinositol3-kinase (PI3K)/protein kinase B (AKT)/Forkhead box protein O1 (FOXO1)/Kruppel-like factor 2 (Klf2) pathway.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Tfh cells in patients with SLE highly express D1-like receptors, which correlate with disease activity. D1-like receptors may promote Tfh cell differentiation through the PI3K/AKT/FOXO1/Klf2 pathway.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Fengxi</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-0605-6158</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiang</LastName><ForeName>Zhongyuan</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Zhenghao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Plastic Surgery, Zhongshan City People's Hospital, Zhongshan, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yi</LastName><ForeName>Ping</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Radiology, Xiangya Hospital, Central South University, Changsha, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Dermatology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China huminjyk@csu.edu.cn chriswu1010@csu.edu.cn yangming_0216@csu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Haijing</ForeName><Initials>H</Initials><Identifier Source="ORCID">0009-0007-7952-3443</Identifier><AffiliationInfo><Affiliation>Department of Dermatology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China huminjyk@csu.edu.cn chriswu1010@csu.edu.cn yangming_0216@csu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China huminjyk@csu.edu.cn chriswu1010@csu.edu.cn yangming_0216@csu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lupus Sci Med</MedlineTA><NlmUniqueID>101633705</NlmUniqueID><ISSNLinking>2053-8790</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.1.-</RegistryNumber><NameOfSubstance UI="D019869">Phosphatidylinositol 3-Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011954">Receptors, Dopamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051057" MajorTopicYN="Y">Proto-Oncogene Proteins c-akt</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019869" MajorTopicYN="N">Phosphatidylinositol 3-Kinases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011954" MajorTopicYN="N">Receptors, Dopamine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">T-lymphocytes, helper-inducer</Keyword><Keyword MajorTopicYN="N">autoimmune diseases</Keyword><Keyword MajorTopicYN="N">lupus erythematosus, systemic</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>17</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>16</Day><Hour>21</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37586763</ArticleId><ArticleId IdType="pmc">PMC10432681</ArticleId><ArticleId IdType="doi">10.1136/lupus-2023-000943</ArticleId><ArticleId IdType="pii">10/2/e000943</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Durcan L, O&#x2019;Dwyer T, Petri M. Management strategies and future directions for systemic lupus erythematosus in adults. Lancet 2019;393:2332&#x2013;43. 10.1016/S0140-6736(19)30237-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)30237-5</ArticleId><ArticleId IdType="pubmed">31180030</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiriakidou M, Ching CL. Systemic lupus erythematosus. Ann Intern Med 2020;172:ITC81&#x2013;96. 10.7326/AITC202006020</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/AITC202006020</ArticleId><ArticleId IdType="pubmed">32479157</ArticleId></ArticleIdList></Reference><Reference><Citation>Kronbichler A, Mayer G. Renal involvement in autoimmune connective tissue diseases. BMC Med 2013;11:95. 10.1186/1741-7015-11-95</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1741-7015-11-95</ArticleId><ArticleId IdType="pmc">PMC3616816</ArticleId><ArticleId IdType="pubmed">23557013</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaban A, Leira EC. Neurological complications in patients with systemic lupus erythematosus. Curr Neurol Neurosci Rep 2019;19:97. 10.1007/s11910-019-1012-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-019-1012-1</ArticleId><ArticleId IdType="pubmed">31773306</ArticleId></ArticleIdList></Reference><Reference><Citation>Crisp&#xed;n JC, Liossis S-NC, Kis-Toth K, et al. . Pathogenesis of human systemic lupus erythematosus: recent advances. Trends Mol Med 2010;16:47&#x2013;57. 10.1016/j.molmed.2009.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2009.12.005</ArticleId><ArticleId IdType="pmc">PMC2823952</ArticleId><ArticleId IdType="pubmed">20138006</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z, Liang Z, Liany H, et al. . Discovery of a novel genetic susceptibility locus on X Chromosome for systemic lupus erythematosus. Arthritis Res Ther 2015;17:349. 10.1186/s13075-015-0857-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-015-0857-1</ArticleId><ArticleId IdType="pmc">PMC4669597</ArticleId><ArticleId IdType="pubmed">26635088</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob CO, Zhu J, Armstrong DL, et al. . Identification of Irak1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proc Natl Acad Sci U S A 2009;106:6256&#x2013;61. 10.1073/pnas.0901181106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0901181106</ArticleId><ArticleId IdType="pmc">PMC2669395</ArticleId><ArticleId IdType="pubmed">19329491</ArticleId></ArticleIdList></Reference><Reference><Citation>Stojan G, Petri M. Epidemiology of systemic lupus erythematosus: an update. Curr Opin Rheumatol 2018;30:144&#x2013;50. 10.1097/BOR.0000000000000480</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000480</ArticleId><ArticleId IdType="pmc">PMC6026543</ArticleId><ArticleId IdType="pubmed">29251660</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok CC. Epidemiology and survival of systemic lupus erythematosus in Hong Kong Chinese. Lupus 2011;20:767&#x2013;71. 10.1177/0961203310388447</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203310388447</ArticleId><ArticleId IdType="pubmed">21148605</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesin L, Ersching J, Victora GD. Germinal center B cell Dynamics. Immunity 2016;45:471&#x2013;82. 10.1016/j.immuni.2016.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2016.09.001</ArticleId><ArticleId IdType="pmc">PMC5123673</ArticleId><ArticleId IdType="pubmed">27653600</ArticleId></ArticleIdList></Reference><Reference><Citation>Crotty S. Follicular helper Cd4 T cells (TFH). Annu Rev Immunol 2011;29:621&#x2013;63. 10.1146/annurev-immunol-031210-101400</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-031210-101400</ArticleId><ArticleId IdType="pubmed">21314428</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco P, Ueno H, Schmitt N. T follicular helper (Tfh) cells in lupus: activation and involvement in SLE pathogenesis. Eur J Immunol 2016;46:281&#x2013;90. 10.1002/eji.201545760</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201545760</ArticleId><ArticleId IdType="pubmed">26614103</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J-Y, Ho JH, Pasoto SG, et al. . Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity. Arthritis Rheumatol 2015;67:988&#x2013;99. 10.1002/art.39020</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39020</ArticleId><ArticleId IdType="pmc">PMC4450082</ArticleId><ArticleId IdType="pubmed">25581113</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujikura D, Ikesue M, Endo T, et al. . Death receptor 6 contributes to Autoimmunity in lupus-prone mice. Nat Commun 2017;8:13957. 10.1038/ncomms13957</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms13957</ArticleId><ArticleId IdType="pmc">PMC5216082</ArticleId><ArticleId IdType="pubmed">28045014</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu D, Walker LSK, Liu Z, et al. . Targeting T(FH) cells in human diseases and vaccination: rationale and practice. Nat Immunol 2022;23:1157&#x2013;68. 10.1038/s41590-022-01253-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-022-01253-8</ArticleId><ArticleId IdType="pubmed">35817844</ArticleId></ArticleIdList></Reference><Reference><Citation>Besedovsky H, del Rey A, Sorkin E. Immune-Neuroendocrine interactions. The Journal of Immunology 1985;135:750&#x2013;4. 10.4049/jimmunol.135.2.750</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.135.2.750</ArticleId><ArticleId IdType="pubmed">4008933</ArticleId></ArticleIdList></Reference><Reference><Citation>Missale C, Nash SR, Robinson SW, et al. . Dopamine receptors: from structure to function. Physiological Reviews 1998;78:189&#x2013;225. 10.1152/physrev.1998.78.1.189</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.1998.78.1.189</ArticleId><ArticleId IdType="pubmed">9457173</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenna F, McLaughlin PJ, Lewis BJ, et al. . Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, Eosinophils and NK cells: a flow Cytometric study. J Neuroimmunol 2002;132:34&#x2013;40. 10.1016/s0165-5728(02)00280-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0165-5728(02)00280-1</ArticleId><ArticleId IdType="pubmed">12417431</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafari M, Ahangari G, Saberi M, et al. . Distorted expression of dopamine receptor genes in systemic lupus erythematosus. Immunobiology 2013;218:979&#x2013;83. 10.1016/j.imbio.2012.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2012.11.002</ArticleId><ArticleId IdType="pubmed">23266246</ArticleId></ArticleIdList></Reference><Reference><Citation>Ugalde V, Contreras F, Prado C, et al. . Dopaminergic signalling limits suppressive activity and gut homing of regulatory T cells upon intestinal inflammation. Mucosal Immunol 2021;14:652&#x2013;66. 10.1038/s41385-020-00354-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-020-00354-7</ArticleId><ArticleId IdType="pubmed">33184477</ArticleId></ArticleIdList></Reference><Reference><Citation>Osorio-Barrios F, Prado C, Contreras F, et al. . Dopamine receptor D5 signaling plays a dual role in experimental autoimmune Encephalomyelitis Potentiating Th17-mediated immunity and favoring suppressive activity of regulatory T-cells. Front Cell Neurosci 2018;12:192. 10.3389/fncel.2018.00192</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00192</ArticleId><ArticleId IdType="pmc">PMC6048279</ArticleId><ArticleId IdType="pubmed">30042660</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao ZX, Miller JS, Zheng SG. An updated advance of Autoantibodies in autoimmune diseases. Autoimmun Rev 2021;20:102743. 10.1016/j.autrev.2020.102743</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102743</ArticleId><ArticleId IdType="pubmed">33333232</ArticleId></ArticleIdList></Reference><Reference><Citation>Jogdand GM, Mohanty S, Devadas S. Regulators of Tfh cell differentiation. Front Immunol 2016;7:520. 10.3389/fimmu.2016.00520</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2016.00520</ArticleId><ArticleId IdType="pmc">PMC5120123</ArticleId><ArticleId IdType="pubmed">27933060</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolence JJ, Kobayashi T, Iijima K, et al. . Airway exposure initiates peanut allergy by involving the IL-1 pathway and T follicular helper cells in mice. J Allergy Clin Immunol 2018;142:1144&#x2013;58. 10.1016/j.jaci.2017.11.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2017.11.020</ArticleId><ArticleId IdType="pmc">PMC6002896</ArticleId><ArticleId IdType="pubmed">29247716</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J-Y, Skon CN, Lee YJ, et al. . The transcription factor Klf2 restrains Cd4+T follicular helper cell differentiation. Immunity 2015;42:252&#x2013;64. 10.1016/j.immuni.2015.01.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2015.01.013</ArticleId><ArticleId IdType="pmc">PMC4409658</ArticleId><ArticleId IdType="pubmed">25692701</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L-T, Wang S-Q, Su J, et al. . Baicalin ameliorates Neuroinflammation-induced depressive-like behavior through inhibition of toll-like receptor 4 expression via the Pi3K/AKT/Foxo1 pathway. J Neuroinflammation 2019;16:95. 10.1186/s12974-019-1474-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1474-8</ArticleId><ArticleId IdType="pmc">PMC6507025</ArticleId><ArticleId IdType="pubmed">31068207</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan S, Huang W, Liu X, et al. . Impdh2 promotes colorectal cancer progression through activation of the Pi3K/AKT/mTOR and Pi3K/AKT/Foxo1 signaling pathways. J Exp Clin Cancer Res 2018;37:304. 10.1186/s13046-018-0980-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13046-018-0980-3</ArticleId><ArticleId IdType="pmc">PMC6282329</ArticleId><ArticleId IdType="pubmed">30518405</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone EL, Pepper M, Katayama CD, et al. . ICOS Coreceptor signaling Inactivates the transcription factor Foxo1 to promote Tfh cell differentiation. Immunity 2015;42:239&#x2013;51. 10.1016/j.immuni.2015.01.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2015.01.017</ArticleId><ArticleId IdType="pmc">PMC4334393</ArticleId><ArticleId IdType="pubmed">25692700</ArticleId></ArticleIdList></Reference><Reference><Citation>Mintz MA, Cyster JG. T follicular helper cells in germinal center B cell selection and Lymphomagenesis. Immunol Rev 2020;296:48&#x2013;61. 10.1111/imr.12860</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12860</ArticleId><ArticleId IdType="pmc">PMC7817257</ArticleId><ArticleId IdType="pubmed">32412663</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson WJ, Jakic B, Labi V, et al. . Orphan nuclear receptor Nr2F6 suppresses T follicular helper cell accumulation through regulation of IL-21. Cell Rep 2019;28:2878&#x2013;91. 10.1016/j.celrep.2019.08.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.08.024</ArticleId><ArticleId IdType="pmc">PMC6791812</ArticleId><ArticleId IdType="pubmed">31509749</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh SV, Almaani S, Brodsky S, et al. . Update on lupus nephritis: core curriculum 2020. Am J Kidney Dis 2020;76:265&#x2013;81. 10.1053/j.ajkd.2019.10.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2019.10.017</ArticleId><ArticleId IdType="pubmed">32220510</ArticleId></ArticleIdList></Reference><Reference><Citation>Papa I, Saliba D, Ponzoni M, et al. . T(FH)-Derived dopamine accelerates productive synapses in germinal centres. Nature 2017;547:318&#x2013;23. 10.1038/nature23013</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature23013</ArticleId><ArticleId IdType="pmc">PMC5540173</ArticleId><ArticleId IdType="pubmed">28700579</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Wu J, Xia X, et al. . Follicular helper T cells: potential therapeutic targets in rheumatoid arthritis. Cell Mol Life Sci 2021;78:5095&#x2013;106. 10.1007/s00018-021-03839-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-021-03839-1</ArticleId><ArticleId IdType="pubmed">33880615</ArticleId></ArticleIdList></Reference><Reference><Citation>Peeva E, Grimaldi C, Spatz L, et al. . Bromocriptine restores tolerance in estrogen-treated mice. J Clin Invest 2000;106:1373&#x2013;9. 10.1172/JCI10420</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI10420</ArticleId><ArticleId IdType="pmc">PMC381463</ArticleId><ArticleId IdType="pubmed">11104790</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakajima A, Sendo W, Tsutsumino M, et al. . Acute sympathetic Hyperfunction in overlapping syndromes of systemic lupus erythematosus and polymyositis. J Rheumatol 1998;25:1638&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">9712113</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson DM, Westlind-Danielsson A. Dopamine receptors: molecular biology, Biochemistry and behavioural aspects. Pharmacol Ther 1994;64:291&#x2013;370. 10.1016/0163-7258(94)90041-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0163-7258(94)90041-8</ArticleId><ArticleId IdType="pubmed">7878079</ArticleId></ArticleIdList></Reference><Reference><Citation>Caielli S, Veiga DT, Balasubramanian P, et al. . A Cd4(+) T cell population expanded in lupus blood provides B cell help through Interleukin-10 and Succinate. Nat Med 2019;25:75&#x2013;81. 10.1038/s41591-018-0254-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0254-9</ArticleId><ArticleId IdType="pmc">PMC6325012</ArticleId><ArticleId IdType="pubmed">30478422</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Yan S-M, Pu Z, et al. . Dopamine signaling promotes tissue-resident memory differentiation of Cd8+ T cells and antitumor immunity. Cancer Res 2022;82:3130&#x2013;42. 10.1158/0008-5472.CAN-21-4084</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-21-4084</ArticleId><ArticleId IdType="pubmed">35802647</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe Y, Nakayama T, Nagakubo D, et al. . Dopamine selectively induces migration and homing of naive Cd8+ T cells via dopamine receptor D3. J Immunol 2006;176:848&#x2013;56. 10.4049/jimmunol.176.2.848</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.176.2.848</ArticleId><ArticleId IdType="pubmed">16393968</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M. Inflammatory markers in systemic lupus erythematosus. J Autoimmun 2020;110:102374. 10.1016/j.jaut.2019.102374</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2019.102374</ArticleId><ArticleId IdType="pubmed">31812331</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatham WW, Furie R, Saxena A, et al. . Long-term safety and efficacy of Anifrolumab in adults with systemic lupus erythematosus: results of a phase II open-label extension study. Arthritis Rheumatol 2021;73:816&#x2013;25. 10.1002/art.41598</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41598</ArticleId><ArticleId IdType="pmc">PMC8252065</ArticleId><ArticleId IdType="pubmed">33225631</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi W, Gupta S, Ricker E, et al. . The Mtorc1-4E-BP-Eif4E axis controls de novo Bcl6 protein synthesis in T cells and systemic Autoimmunity. Nat Commun 2017;8:254. 10.1038/s41467-017-00348-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00348-3</ArticleId><ArticleId IdType="pmc">PMC5557982</ArticleId><ArticleId IdType="pubmed">28811467</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>